RETACRIT Trademark

Trademark Overview

On Friday, February 17, 2017, a trademark application was filed for RETACRIT with the United States Patent and Trademark Office. The USPTO has given the RETACRIT trademark a serial number of 87340145. The federal status of this trademark filing is REGISTERED as of Tuesday, June 4, 2019. This trademark is owned by Hospira, Inc.. The RETACRIT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical drug for the treatment of anemia
retacrit

General Information

Serial Number87340145
Word MarkRETACRIT
Filing DateFriday, February 17, 2017
Status700 - REGISTERED
Status DateTuesday, June 4, 2019
Registration Number5770173
Registration DateTuesday, June 4, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2017

Trademark Statements

Goods and ServicesPharmaceutical drug for the treatment of anemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 24, 2017
Primary Code005
First Use Anywhere DateWednesday, November 14, 2018
First Use In Commerce DateWednesday, November 14, 2018

Trademark Owner History

Party NameHospira, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045
Party NameHospira, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045
Party NameHospira, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045

Trademark Events

Event DateEvent Description
Tuesday, February 21, 2017NEW APPLICATION ENTERED
Friday, May 12, 2017ASSIGNED TO EXAMINER
Friday, February 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 20, 2018SOU TEAS EXTENSION RECEIVED
Monday, May 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2017PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 14, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, February 14, 2018SOU EXTENSION 1 FILED
Wednesday, February 14, 2018SOU EXTENSION 1 GRANTED
Friday, February 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 20, 2018SOU EXTENSION 2 FILED
Monday, August 20, 2018SOU EXTENSION 2 GRANTED
Tuesday, April 9, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, April 9, 2019USE AMENDMENT FILED
Sunday, April 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, April 21, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, April 29, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 15, 2019SOU TEAS EXTENSION RECEIVED
Friday, February 15, 2019SOU EXTENSION 3 FILED
Friday, February 15, 2019SOU EXTENSION 3 GRANTED
Tuesday, February 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 4, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, June 4, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

retacrit anemia treatment drug pharmaceutical